<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>ERBA Diagnostics Inc (ERB): Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside - Seeking Alpha</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta http-equiv="P3P" content='CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"' />

<script>
    (function(_,e,rr,s){_errs=[s];var c=_.onerror;_.onerror=function(){var a=arguments;_errs.push(a);
    c&&c.apply(this,a)};var b=function(){var c=e.createElement(rr),b=e.getElementsByTagName(rr)[0];
    c.src="//beacon.errorception.com/"+s+".js";c.async=!0;b.parentNode.insertBefore(c,b)};
    _.addEventListener?_.addEventListener("load",b,!1):_.attachEvent("onload",b)})
    (window,document,"script","4ffae9d6f05d1da630000008");
</script>

<script type='text/javascript'>
try {
  window.external.msSiteModeCreateJumplist('SeekingAlpha - Read, Decide, Invest.');
  window.external.msSiteModeAddJumpListItem('Portfolio' ,
  'http://seekingalpha.com/account/portfolio?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Market Currents - Real-time stock market news updates' ,
  'http://seekingalpha.com/currents/all?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Investment Ideas' ,
  'http://seekingalpha.com/dashboard/investing_ideas?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Income Investing, Retirement Investing and Dividend Stocks' ,
  'http://seekingalpha.com/dashboard/investing_income?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('ETFs & Portfolio Strategy' ,
  'http://seekingalpha.com/dashboard/etfs?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('Macro View, Market Economy' ,
  'http://seekingalpha.com/dashboard/macro_view?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
  window.external.msSiteModeAddJumpListItem('My Email Alerts' ,
  'http://seekingalpha.com/account/email_preferences?source=ie_task',
  'http://static.cdn-seekingalpha.com/favicon.ico');
} catch (ex) {
}
</script>
<meta name="application-name" content="Seeking Alpha - Read, Decide, Invest."/>
<meta name="msapplication-TileColor" content="#360000"/>
<meta name="msapplication-TileImage" content="http://static.cdn-seekingalpha.com/images/media_kit/71cdea92-2dc1-419d-8d62-f68b74c1eda8.png"/>
<meta name="msapplication-tooltip" content="Seeking Alpha - Read, Decide, Invest." />
<meta name="msapplication-starturl" content="http://seekingalpha.com?source=ie_task" />
<meta name="msapplication-task" content="name=Portfolio ;action-uri=http://seekingalpha.com/account/portfolio?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Market Currents - Real-time stock market news updates ;action-uri=http://seekingalpha.com/currents/all?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Investment Ideas ;action-uri=http://seekingalpha.com/dashboard/investing_ideas?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Income Investing, Retirement Investing and Dividend Stocks ;action-uri=http://seekingalpha.com/dashboard/investing_income?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=ETFs & Portfolio Strategy ;action-uri=http://seekingalpha.com/dashboard/etfs?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=Macro View, Market Economy ;action-uri=http://seekingalpha.com/dashboard/macro_view?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<meta name="msapplication-task" content="name=My Email Alerts ;action-uri=http://seekingalpha.com/account/email_preferences?source=ie_task;icon-uri=http://static.cdn-seekingalpha.com/favicon.ico" />
<!-- End IE9 Settings -->

<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@sa_popular">
<meta name="twitter:title" content="Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside">
<meta name="twitter:description" content="Erba Diagnostics (ERB) is a fully integrated in vitro diagnostics company that has been in the midst of a turnaround for more than three years. The company was once a subsidiary of Phillip Frost's Ivax Corporation (previously named Ivax Diagnostics), and spun off into its own entity after Suresh Varizani bought the company in 2010 for approximately $15 million. Suresh Varizani is a Mumbai based entrepreneur who founded Transasia in 1979 with ">
<meta name='twitter:image' content='http://static.cdn-seekingalpha.com/images/users_profile/005/387/331/big_pic.png?1366049036'><link rel="search" type="application/opensearchdescription+xml" href="/javascripts/seeking.xml" title="SeekingAlpha Search" />
<meta name="description" content="ERBA Diagnostics Inc (NYSEMKT:ERB): Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside" /><meta name="robots" content="noarchive" /><meta name="keywords" content="NYSEMKT:ERB" /><link rel="alternate" media="only screen and (max-width: 640px)" href="http://m.seekingalpha.com/article/1840392" /><meta name="original-source" content="http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside"><meta property="og:image" content="http://static.cdn-seekingalpha.com/uploads/2013/8/19/social_sa_logo.png" />
<meta property="og:title" content="Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside" />
<meta property="og:description" content="Erba Diagnostics (ERB) is a fully integrated in vitro diagnostics company that has been in the midst of a turnaround for more than three years. The company was once a subsidiary of Phillip Frost's Ivax Corporation (previously" />
<link rel="canonical" href="http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside" />
<link href="http://static1.cdn-seekingalpha.com/stylesheets/performance_layout_packaged.css?1384954027" media="screen" rel="stylesheet" type="text/css" /><link href="http://static1.cdn-seekingalpha.com/stylesheets/performance_layout_b_packaged.css?1384954027" media="screen" rel="stylesheet" type="text/css" /><link href="http://static1.cdn-seekingalpha.com/stylesheets/article_packaged.css?1384954028" media="screen" rel="stylesheet" type="text/css" />
<script type="text/javascript">var block_script = true;var jhi = 0;</script>
<script type="text/javascript" src="/javascripts/getads.js"></script>


<script type="text/javascript">
  var users_on_site='2,666,624';
  var user_cookie={};

  function readCookie(name) {
    var cookie = document.cookie.match(new RegExp('(^|;)\\s*' + escape(name) + '=([^;\\s]*)'));
    return (cookie ? unescape(cookie[2]) : null);
  }

  function addToCookie(key,value) {
    var arr=user_cookie[key].split(',');
    arr.push(value);

    user_cookie[key]=arr.join(',');
  }
  if (document.location.protocol == "https:") {
    document.write('<scr'+'ipt src="/account/no_cookie_key"></scri'+'pt>');
  } else if (readCookie('user_cookie_key')) {
    document.write('<scr'+'ipt src="http://static.cdn-seekingalpha.com/account/cookie/'+readCookie('user_cookie_key')+'"></scri'+'pt>');
  } else if (readCookie('user_id')) {
    document.write('<scr'+'ipt src="http://seekingalpha.com/account/no_cookie_key"></scri'+'pt>');
  }
  
    (function(){
      var url='/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside';
      if (location.pathname!=url){
        if (window.history && history.replaceState) history.replaceState("", "", url+location.search);
        else location.href=url+location.search;
      }
    })();

  var isThisMyFirstPV = false;
  var _comscore = _comscore || [];
  _comscore.push({ c1: "2", c2: "8500672" });
  (function() {
    var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
    s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
    el.parentNode.insertBefore(s, el);
  })();
  var _sf_startpt=(new Date()).getTime(); // chartbeat code
  var is_pro = false;
  if (document.location.protocol == "https:") {
    document.write('<link rel="shortcut icon" type="image/ico" href="https://seekingalpha-a.akamaihd.net/favicon.ico" />')
  } else {
    document.write('<link rel="shortcut icon" type="image/ico" href="http://static.cdn-seekingalpha.com/favicon.ico" />')
  }
  
    
  var ASSET_HOSTS = ["http://static.cdn-seekingalpha.com","http://static1.cdn-seekingalpha.com","http://static2.cdn-seekingalpha.com","http://static3.cdn-seekingalpha.com"];
</script>

<script type='text/javascript'>
  if (document.location.protocol !== "https:") {
    var crtg_nid="2227";
    var crtg_cookiename="cto_sa";
    var crtg_varname="crtg_content";
    function crtg_getCookie(c_name){ var i,x,y,ARRCookies=document.cookie.split(";");for(i=0;i<ARRCookies.length;i++){x=ARRCookies[i].substr(0,ARRCookies[i].indexOf("="));y=ARRCookies[i].substr(ARRCookies[i].indexOf("=")+1);x=x.replace(/^\s+|\s+$/g,"");if(x==c_name){return unescape(y);}}return'';}
    var crtg_content = crtg_getCookie(crtg_cookiename);var crtg_rnd=Math.floor(Math.random()*99999999999);
    var crtg_url=location.protocol+'//rtax.criteo.com/delivery/rta/rta.js?netId='+escape(crtg_nid);crtg_url+='&cookieName='+escape(crtg_cookiename);crtg_url+='&rnd='+crtg_rnd;crtg_url+='&varName=' + escape(crtg_varname);
    var crtg_script=document.createElement('script');crtg_script.type='text/javascript';crtg_script.src=crtg_url;crtg_script.async=true;
    if(document.getElementsByTagName("head").length>0)document.getElementsByTagName("head")[0].appendChild(crtg_script);else if(document.getElementsByTagName("body").length>0 && !SA.Utils.Env.isIE7)document.getElementsByTagName("body")[0].appendChild(crtg_script);
  }
</script>
<script src="http://static2.cdn-seekingalpha.com/javascripts/common_packaged.js?1384953986" type="text/javascript"></script>
<script src="http://static2.cdn-seekingalpha.com/javascripts/common2_packaged.js?1384953988" type="text/javascript"></script><script src="http://static.cdn-seekingalpha.com/javascripts/common_article_packaged.js?1384953990" type="text/javascript"></script><script src="//partner.googleadservices.com/gampad/google_service.js" type="text/javascript"></script>
<script>
  if (SA.Data && SA.Data.Cache) {
    var adata = SA.Data.Cache.get('campaign_content');
  }
</script>

<script type="text/javascript">
  if ((user_email_cookie=readCookie('user_email')) && user_email_cookie.indexOf('@gmail.com')!=-1) {
    createCookie('user_email',(user_email_cookie.replace('@gmail.com','').replace(/\./gi,'').replace(/\+(.*?)$/,''))+'@gmail.com',365);
  }

  if (typeof(readCookie) == "function" && readCookie('user_vocation')) {
    createCookie('u_voc',readCookie('user_vocation'),3000);
  }
  if (readCookie('sapu') == "121") {eraseCookie('sapu');}
  var user_cookie = user_cookie || {};
  eraseCookie("__article_last_size");

if (top.location.pathname == "/" && readCookie('user_id')==957061) {
  var old_SADataCookies = SA.Data.Cookies.get;
  SA.Data.Cookies.get = function(x){if (x=="user_following_users" || x=="user_watchlist_authors") return ""; else return old_SADataCookies(x);}
}
  try{(function(){
    var uc=SA.Data.Cookies.get("user_cookie_key"), t=uc ? uc.match(/t=([0-9]+)/) : null;
    if (t && t[1] < 1367771521) SA.Data.Cookies.set("user_cookie_key","");
  })();} catch(e){}
</script>

<script type="text/javascript">var NREUMQ=NREUMQ||[];NREUMQ.push(["mark","firstbyte",new Date().getTime()]);</script>      <script type="text/javascript">
  var adblock = false;
  try{
    GS_googleAddAdSenseService("ca-pub-1420150919334552");
    GS_googleEnableAllServices();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense1","adsense down");
  }
</script>
<script type="text/javascript">
  try{
      GA_googleAddSlot_sa('Article_120x30');
    GA_googleFetchAds();
  } catch(e) {
    adblock = true;
    Mone.event("Exception","adsense2","adsense down");
  }
</script>  </head>
    <body class="stretch_bg">
    <script>
  var ms_slug = '';
  var article_dashboards = '@investing-ideas@sectors@';
  var article_sectors_themes = '@insider-ownership@small-cap-insight@us@medical-instruments-supplies@editors-picks@healthcare@article@';
  var ratings_hash={};
  var ARTICLE_ID = 1840392;
  var ARTICLE_TYPE = "standard";
  var ARTICLE_LOCK = "";
  var author_slug = "charles-fox";
  var pticker_for_ads = "erb";
  var time_left;
  var lock_comments = false;
  var machine_cookie = readCookie('machine_cookie');
  var middle_version = ABTest.identity%10;
  var sector_name = "Healthcare";
  var sector_slug = "healthcare";
  try {
    window.sessionStorage.setItem("/article/"+ARTICLE_ID, '1');
  } catch (error) {}

  
</script>
<script>var mone_article_tags = "{erb};;;{healthcare};;;{insider-ownership,small-cap-insight,us,medical-instruments-supplies,editors-picks,investing-ideas,sa-exclusive};;;{charles-fox}"</script><script>var ord = Math.floor(Math.random()*1000000000);</script>
<span class="seeking_alpha_site_title">Seeking Alpha</span>
<script type="text/javascript">
  if (readCookie('sa_mobile') == '1') {
    var aHTML =[];
    aHTML.push('<div class="mobile_or_full_site">');
      aHTML.push('<span class="mobile_site" onclick="eraseCookie(\'sa_mobile\');top.location.reload()">Click here to view mobile site</span>');
      aHTML.push('<div class="cleaner"></div>');
    aHTML.push('</div>');
    document.write(aHTML.join(""));
  }
</script>
<div class="promotion_cnt finance stars ipad_top">
  <div close="close"></div>
    <a onclick='Mone.event("ipad_promotion_top","top_ipad_banner_large","ipad_promotion_top_click");' href="/download-ipad-app?source=top_ipad_banner_large" class="promotion_video">
    <div class="ptext">
      <div class="ptext_t">Seeking Alpha Portfolio App for iPad</div>
      <div class="ptext_h">Finance</div>
      <div id='ipad_stars' class="stars stars_5"></div>
      <div class="rate">(<span class="rate_num" id="rate_num">1</span>)</div>
    </div>

    <div class="free"></div>
    <div class="sep"></div>
    <div class="ipad_screenshots"></div>
  </a>
</div>
<script>
  var ipadData;
  SeekingAlpha.Initializer.AddAfterLoad(function(){
    if (SA.Utils.Env.isIPad && !/3/.test(SA.Data.Cookies.get("user_devices"))){
      Mone.event("ipad_promotion_top","top_ipad_banner_large","ipad_promotion_displayed");
      ipadData = new SA.Data.iPad();
      ipadData.instanceName = "ipadData";
      var responseHandler = new Object();
      responseHandler.handleResponse = function(data){
        if (!data.averageUserRating) return;
        var stars = data.averageUserRating < 4 ? "4" : (data.averageUserRating+"").replace(".","");
        $("ipad_stars").className = "stars stars_"+stars;
        $("rate_num").innerHTML = data.userRatingCount;
      }
      ipadData.responseDelegate = responseHandler;
      ipadData.getData();
    }
    if (SA.Utils.Env.isIPad && !/3/.test(SA.Data.Cookies.get("user_devices"))) {
      $$("body")[0].addClassName('ipad_promotion')
    }
  });
</script>
<div id="header" class="not_logged_in header_nav">
  <div id="logo_and_navigation" class="logo_and_primary_navigation">
    <div id="comment_popup" style="position:relative; left:0; display:none">
  <div id="popup_secondary">
    <div id="inner_popup"></div>
  </div>
</div>    <span class="logo_old_h1"><a href="http://seekingalpha.com/" title="Seeking Alpha - Home Page" sasource="salogo"></a></span>
    
      <div class="item banner728x90" id='top_banner_728x90'>
          <script type="text/javascript">
            iframeAd("728x90",'http://ad.doubleclick.net/adj/sek.investing-ideas/insider-ownership;sz=728x90;x=x;tile=1;d=investing-ideas;t=insider-ownership;aid=1840392;d=investing-ideas;d=sectors;t=insider-ownership;t=small-cap-insight;t=us;t=medical-instruments-supplies;t=editors-picks;t=healthcare;t=article;z=1;a=charles-fox;cnt=7;cnt=21;cnt=5;cnt=20;cnt=24;cnt=26;cnt=27;pr=erb;s=erb;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');
          </script>
      </div>
    
  </div>
  <div class='nav_container_wrap' id='nav_container_wrap'>
  <div id="nav_container" headtab="">
    <div id="navi_cont">
      <ul id="navi" class="navi">
        <li thistab='home' class="home">
          <a href="http://seekingalpha.com/" sasource="headtabs">Home</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='portfolio' class="portfolios">
          <a href="http://seekingalpha.com/account/portfolio" sasource="headtabs">Portfolio</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='market_news'>
          <a href="http://seekingalpha.com/currents/all" sasource="headtabs">Market Currents</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='investing_ideas'>
          <a href="http://seekingalpha.com/dashboard/investing_ideas" sasource="headtabs">Investing Ideas</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='investing_income'>
          <a href="http://seekingalpha.com/dashboard/investing_income" sasource="headtabs">Dividends &amp; Income</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='etfs'>
          <a href="http://seekingalpha.com/dashboard/etfs" sasource="headtabs">ETFs</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='macro_view'>
          <a href="http://seekingalpha.com/dashboard/macro_view" sasource="headtabs">Macro View</a>
          <span class="navi_right_corner">|</span>
        </li>
        <li thistab='alerts'>
          <a href="http://seekingalpha.com/real-time-alerts" sasource="headtabs">ALERTS</a>
            <span class="navi_right_corner">|</span>
          </li>
          <li thistab='pro' class="pro_tab">
            <a href="http://seekingalpha.com/account/pro" sasource="headtabs">PRO</a>
          </li>
        <li class="right_section">
          <div id="user_settings_wrapper"></div>
        </li>
      </ul>
    </div>
  </div>
    <div class="rta_nav">
      <span class="rta_nav_wrap">
        <div id="rta_nav_close" onclick="SA.Promotion.Sticky.hide()" class="close_rta">&nbsp;</div>
        <div id="related_promo_container_rel_nav" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title_nav">This article was sent to <span id="promo_num_of_rta_rel_nav">94</span> people who get email alerts on <span class="replace_by_rel_slug">&nbsp;</span>.</div>
      <div class="title_sec">Which cover: new articles | breaking news | earnings results | dividend announcements</div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel_nav')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div>
  <div class="m_pop point_left" id="promotion_box_rel_nav" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel_nav" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to <span id="dash_newsl_subscr_count_ph_nav">371,443</span> people who get the Investing Ideas newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel_nav', 10727)">Get the Investing Ideas newsletter &raquo;</span>
    <span id="promo_no_rel_loader_nav" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel_nav" style="display:none;"></div>
</div>
                              </span>
    </div>
</div>
  <script type="text/javascript">
    SeekingAlpha.Initializer.LogAndRun(SA.Navigation.Top.init);
  </script>
</div>
<div id="main_container" class="white_as_before ">
  <div id="content_wrapper" class="article_pages" itemscope itemtype="http://schema.org/Article">
    <img src="http://static.cdn-seekingalpha.com/images/universal/print_logo.png" width="48" height="20" id="print_seekingalpha_logo" />
    <div class="page_top">
      <div class="search_box_container_isolated">
  <div class="search_box">
    <form id="search_box_sa_search" method="get" class="linktosym comp search" action="/search/" onsubmit="return false;">
      <fieldset>
        <input id="autocomplete_sa_search" class="input_text text" type="text" value="search by symbol, author, keyword..." size="25" autocomplete="off" onblur="if($$('.search_box'))$$('.search_box')[0].style.background='';this.style.color=this.value=='' ? '#8D8D8D' : '#000000';handleInput(this,'blur')" onfocus="if($$('.search_box'))$$('.search_box')[0].style.background='#fff';this.style.color='#000000';handleInput(this,'focus')" afteruploadvalue='eFind quotes, people, expressions, transcripts' title='search by symbol, author, keyword...' class="find_transcripts" />
        <input type="button" class="search_button" value="" onclick="if ($('autocomplete_sa_search').value!=$('autocomplete_sa_search').title) AutoCompleteSAConfig.Packages.search.Find()" />
      </fieldset>
      <input type="hidden" name="source" value="search_general" />
      <input type="hidden" id="autocomplete_sa_hidden_search" name="q" value="" />
      <input type="hidden" name="cx" value="018269914407235029540:cdhc2yeo2ko" />
      <input type="hidden" name="cof" value="FORID:11;NB:1" />
      <input type="hidden" name="goto_search_tab" value="" />
    </form>
    <script type="text/javascript">SeekingAlpha.Initializer.LogAndRun(function () { AutoCompleteSAConfig.Load('search', { Symbols:true, IframeCover:true, AfterInsert:function () { this.Find(); }, AfterSubmit:function () { this.Find(); }}) });</script>
    <script type="text/javascript" src="http://www.google.com/coop/cse/brand?form=searchbox_018269914407235029540%3Acdhc2yeo2ko&lang=en"></script>
  </div>
</div>
      <div id="article_header" class="article_content">
  <div class="top_content">
    <div id="page_header" class="page_header_email_alerts">
      <h1>
        <span itemprop="name">Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside</span>
              </h1>
      <div id="article_info">
        
        <div class="article_info_pos">
          <span>Nov 14 2013, 13:28</span>
          <span id='title_article_comments'></span>
          <span id="page_position"></span>
          <span class="author_name_for_print">by: Charles Fox</span>
<span  class='print_hide'>&nbsp;|&nbsp;</span>
            <span class='print_hide'>about:</span> <span  class='print_hide' id='about_primary_stocks'><a href="/symbol/erb" title='ERBA Diagnostics, Inc.' sasource='article_primary_about'>ERB</a></span>                   	</div>
        <div id="bookmark_top" class="bookmark_container">
  <div id="bookmark_title_top" class="bookmark_title">BOOKMARK<span class="added">ED</span><span class="add"> / READ LATER</span></div></span>
  <div class="bookmark_popup" id="bookmark_popup_top">
    <h2>Bookmarked</h2>
    <p>Added to your bookmarks on the Seeking Alpha homepage</p>
    <div id="btn_top" class="btn">Remove Bookmark</div>
    <div class="arr"></div>
    <div class="right_cor"></div>
  </div>
</div>
<script>
 new SA.Pages.Article.bookmark("_top");
</script>
      </div>
    </div>
  </div>
</div>
<div class="cleaner"></div>
    </div>
    <div class="cleaner"></div>
    <div id="main_content" class="no_big_gaps_main_content">
      
      <div id="article_body_container" class="no_big_gaps_article_body_container" style="float:right;">
        <div id="article_body" itemprop="articleBody">
          <div id="article_body_top2" class="disclosure_top" style="display:none;"></div>
          <p>Erba Diagnostics (<a href='http://seekingalpha.com/symbol/erb' title='ERBA Diagnostics, Inc.'>ERB</a>) is a fully integrated in vitro diagnostics company that has been in the midst of a turnaround for more than three years. The company was once a subsidiary of Phillip Frost's Ivax Corporation (previously named Ivax Diagnostics), and spun off into its own entity after Suresh Varizani bought the company in 2010 for approximately $15 million. Suresh Varizani is a Mumbai based entrepreneur who founded Transasia in 1979 with <a href="http://businesstoday.intoday.in/story/best-emerging-companies-2013-transasia-bio-medicals/1/198794.html" rel="nofollow">an initial bankroll of $5</a>, and is currently the CEO of Erba Diagnostics Manheim. Through Erba Manheim, Varizani owns 82.4% of Erba Diagnostics. Erba Manheim is the parent company of Erba Diagnostics.</p><p>Erba Diagnostics, through the acquisition and consolidation of several companies, is composed of five separate divisions, including Delta Biologicals, Diamedix, ImmunoVision, Drew Scientific, and JAS Diagnostics. The company's positive 3Q 2013 earnings results, management's continued mention of consolidation and acquisitions, and the clear synergies between Erba Diagnostics and the other five divisions of Erba Manheim lead me to believe that Erba Diagnostics is in the midst of steadily acquiring and consolidating every division of Erba Manheim into themselves. Varizani would most likely run this combined, publicly traded company, and it would be years in the making. With shares trading at $1.70, and a current market cap of $68 million, now is a prime entry point for the speculative investor who believes something big is brewing at Erba.</p><p><strong>Overview</strong></p><p>The divisions of Erba Diagnostics provide an array of products and devices, including the MAGO series instruments, clinical chemistry reagents, and diagnostic reagents, which are sold internationally through many distribution channels. The picture below illustrates a clearer image of the structure of Erba.</p><p><em>(click to enlarge)</em><a href="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId5.png" rel="lightbox" rel="nofollow"><img src="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId5_thumb.jpg" /></a></p><p>When you buy shares of ERB, you are buying a share of Erba Diagnostics (<a href='http://seekingalpha.com/symbol/usa' title='Liberty All-Star Equity Fund'>USA</a>), and its five subsidiaries. Erba Manheim and its five other subsidiaries are not publicly traded as of now. Erba Diagnostics collaborates with the other divisions of Erba Manheim. The divisions of Erba Manheim include:</p><p>Founded in 1979, <strong>Transasia</strong> provides end-to-end solutions in biochemistry, hematology, immunology, critical care, coagulation, urine analysis, diabetes, microbiology and molecular diagnosis. The company is one of India's largest producers of diagnostic equipment, exports to 90 countries, and achieved sales of approximately $200 million last year.</p><p><strong>Erba Russia</strong> is a growing marketing company that offers sales and after sales service to its customers with products including urine analysis, clinical chemistry, microbiology and hematology. The company employs approximately 120 people.</p><p><strong>Erba France</strong> specializes in the design, development, and manufacturing of automated analyzers and reagents in the field of clinical chemistry, hemostatsis, and immunology. Erba France has more than 1,000 employees, operates in 70 countries, and generates annual revenue of approximately $150 million.</p><p><strong>Erba Lachema</strong>, located in the Czech Republic, develops, manufactures, and sells products for urine analysis, clinical chemistry, microbiology, and hematology.</p><p><strong>Erba DDS</strong>, located in Turkey and established in 1993, develops, manufactures, and markets in-vitro diagnostic products in the field of urine analysis, biochemistry, and hematology. The company does business in 15 different countries throughout the Middle East.</p><p>There are many similarities between the companies that make up Erba Manheim (above), and the companies that make up Erba Diagnostics USA (below).</p><p><strong>Erba Diagnostics</strong> is a fully integrated in vitro diagnostics company that develops, manufactures, and distributes diagnostic reagents, test kits and instrumentation for autoimmune and infectious diseases throughout the US and globally.</p><p><strong>Delta Biologicals</strong>, located in Italy, manufactures and distributes the MAGO product line, and in vitro diagnostic products for hospitals and medical laboratories. The MAGO is an automated immunoassay system.</p><p><strong>Diamedix</strong> manufactures in vitro diagnostic kits marketed in conjunction with the MAGO system. The company also offers autoimmune and infectious disease test kits. The company has obtained FDA approval for their products.</p><p><strong>ImmunoVision</strong> is based in Arkansas and develops and manufactures a range of antibodies and antigens for use in diagnostic reagents.</p><p><strong>Drew Scientific</strong> provides reagents and analytical instruments for the field of diabetes management, hematology, and clinical chemistry. They are specialists in blood analysis. Erba acquired the company in 2012 and their systems are renowned for their high performance.</p><p><strong>Jas Diagnostics</strong> is a manufacturer of clinical chemistry reagents, and has established sales in the US, Latin America, Africa, and Asia. Jas diagnostics was a subsidiary of Drew Scientific, which was acquired by Erba in 2012 for $6.5 million. The combined revenues of Jas and Drew <a href="http://www.businesswire.com/news/home/20121004005416/en/ERBA-Diagnostics-Acquires-Escalon-Medical-Corp.-Clinical" rel="nofollow">for 2012 were $13 million</a>.</p><p>The partnership between Erba Diagnostics and Erba Manheim has led to collaborations and cost savings for the publicly traded company. In December of 2012, JAS Diagnostics worked on research and development with Erba France, subject to terms that JAS diagnostics covered the cost of the research by paying Erba France seven monthly payments of $50,000 and then some. However, on July 24, 2013, JAS and Erba France mutually terminated the financial agreement above and Erba France refunded JAS's entire payment, which totaled approximately $739,000. This led to significant cost savings for the company.</p><p>Another example, Erba Manheim charges Erba Diagnostics an annual fee of $1 to license and use the name Erba. More cost saving collaborations of this nature should be expected between Erba Manheim and Erba Diagnostics in the future.</p><p>All 11 companies mentioned above, and recently formed Erba Mexico will be joining Erba Manheim at the 2013 Medica trade fair, the largest international medical exhibition, taking place in Dusseldorf, Germany next week, between November 20th and 23rd.</p><p><em>(click to enlarge)</em><a href="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId7.png" rel="lightbox" rel="nofollow"><img src="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId7_thumb.jpg" /></a></p><p>During this time, I expect the divisions to review and update their strategy moving forward as a whole, together. The similarities between these divisions are pointing to one consolidated entity in the future. This combined company would have distribution channels that cover the globe and experience accretive earnings as the many possible mergers take place.</p><p><strong>Earnings Results</strong></p><p>Erba Diagnostics released their quarterly earnings on November 11th, and investors liked what they saw, with shares jumping upwards of 20% before closing the day with gains of 13%. The company achieved positive net income for the second quarter in a row, with revenues increasing 83% to $6.9 million, and gross profit margin increasing 46% when compared to 3Q 2012. Net income stood at $130,000 for the three months ended September 30th.</p><p>The company has been experiencing accelerated growth in the sale of its high margin reagent products, and the recent acquisition of Drew Scientific has significantly contributed to the company's top and bottom lines. Drew Scientific's 3Q revenue stood at $3,489,000, representing approximately half of Erba's total revenue. Drew achieved a gross profit margin of approximately 43%. The integration of Drew Scientific will continue to lead revenues higher and is expected to lower operating expenses over time.</p><p>The company also expects to see an uptick in sales as the Affordable Care Act is implemented in the US. Currently, the company is doubling the production capacity at its Miami Lakes facility, and will be buying two vacant buildings next to the plant. The organic growth stemming from Erba Diagnostics and its five subsidiaries is almost as exciting as the potential growth through acquisitions.</p><p>Erba Diagnostics recently set up a subsidiary in Mexico, where the in vitro diagnostics (IVD) market <a href="http://online.wsj.com/article/PR-CO-20131104-904474.html" rel="nofollow">is expected to surpass $400 million</a> this year. The US IVD market is expected to <a href="http://www.ivdtechnology.com/article/us-ivd-market-exceed-95-billion-2017" rel="nofollow">reach $9.5 billion by 2017</a>. Analysts predict that the IVD market will be the largest in the Medtech sector by 2018, with forecasted sales reaching approximately $62 billion by 2016. Getting far ahead of us, analysts predict the market <a href="http://www.ivdtechnology.com/blog/ivdt-insight/slow-poor-diagnoses-fuel-strong-ivd-sales-says-research-firm" rel="nofollow">to reach $126 billion</a> in sales in 2022; long-term growth is not letting up. Erba Diagnostics is well positioned to capitalize off of this growing market, and the company continues to seek and fulfill opportunities of geographical expansion.</p><p><img src="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId11.png" /><em>(click to enlarge)</em><a href="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId12.png" rel="lightbox" rel="nofollow"><img src="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId12_thumb.jpg" /></a></p><p>Comments from Erba's interim CEO Sanjiv Suri reaffirmed the idea that the company is looking to merge with other companies, and the synergy and likely cost efficiencies makes Erba Manheim and its subsidiaries a likely target. <a href="http://www.news-medical.net/news/20131111/ERBA-Diagnosticse28099-net-revenues-increase-8325-to-246941000-in-third-quarter-2013.aspx" rel="nofollow">Suri stated</a>, &quot;We continue to consolidate our operations as well as to implement a number of new initiatives in an effort to grow sales and expand the product range&hellip;We continue to explore potential acquisitions, both in the United States and internationally.&quot;</p><p>The efforts of an acquisition would be supported by Erba Manheim's stock purchase and warrant agreement, which would give Erba Diagnostics access to nearly $30 million in funding.</p><p><strong>Stock Price Needs to Rise For Consolidation to Occur</strong></p><p>If Suresh Varizani is truly planning on merging the subsidiaries of Erba Manheim with publicly traded Erba Diagnostics, then the share price of ERB needs to appreciate beforehand. Because Varizani owns 82.4% of the company, he cannot simply merge Erba Diagnostics with his other private businesses because his ownership of the overall company would be too high, and the company would lose its public listing status. Therefore, Varizani needs to offer shares in order to reduce his ownership and allow mergers between the two companies to take place.</p><p>However, I do not believe Varizani wants to offer shares and dilute at today's market price, which he most likely views as extremely undervalued. The future release of positive earnings, possible stock repurchases, and continued business expansion should over time help raise the price of the stock to a level where Varizani would feel comfortable offering up shares (possibly around $4 per share), which would signal the green light for a merger between a subsidiary of Erba Manheim with Erba Diagnostics. Most of the mergers would be earnings accretive for Erba Diagnostics, and as the share price continues to rise, Varizani would continue to offer more shares and then incorporate more of Erba Manheim into Erba Diagnostics. If Erba Diagnostics eventually acquires all of Erba Manheim, their share price should surpass $15. The combined revenues of this hypothetical company would generate sales upwards of $600 million.</p><p>This company has approximately 43 million shares outstanding, and only has a float of 7 million shares. This is a thinly traded company, and it wouldn't take a great deal of news to drive up the stock.</p><p><strong>Conclusion</strong></p><p>Erba Diagnostics is a profitable, expanding, small cap company that is well positioned in a growing market at an exciting time. The risks associated with any small cap company apply to Erba. This is a volatile stock, and the company has an accumulated deficit of approximately $36 million. There is also heavy competition for established companies such as Roche, Abbott, Siemens, and more. Dilution is also a risk for shareholders, and the sheer amount of work (legal, SEC paperwork etc.) needed to complete these mergers is a testament to how long this process may actually take.</p><p>At the same time, this company has a healthy balance sheet, has achieved profitability, and only has long-term debt of $1.5 million. The current valuation of Erba is out of whack. Revenues will improve as the company continues to consolidate the operations of Drew Scientific and Jas Diagnostics. The company has access to global distribution channels thanks to the many subsidiaries of Erba Manheim, and it's only a matter of time before the two companies consolidate and take advantage of the many synergies between the two. Management is dropping hints everywhere, and when you browse the websites of these 12 different companies, you realize that they should be pieced together.</p><p><em>(click to enlarge)</em><a href="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId14.png" rel="lightbox" rel="nofollow"><img src="http://static.cdn-seekingalpha.com/uploads/2013/11/5387331_13844465639987_rId14_thumb.jpg" /></a></p><p>Information was sourced from Erba's latest <a href="http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0001144204-13-060230" rel="nofollow">10-Q</a>, and <a href="http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0001144204-13-035055" rel="nofollow">10-K</a></p>
            <div id="article_source">Source: <a href="/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside?source=cc">Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside</a></div>
            <!--googleoff: index-->
            <div id="article_body_top" class="disclosure_top" style="display:none;">
              <p><strong>Disclosure: </strong>I am long <a href='http://seekingalpha.com/symbol/erb' title='ERBA Diagnostics, Inc.'>ERB</a>. <span id="additional_business_disclosure" style="display:none">I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.</span> <span onclick='uncollapse()' id='more_button' style='cursor:pointer'><strong>(More...)</strong></span></p>
              <span id="business_disclosure" style="display:none"></span>
            </div>
            <div style="clear:both"></div>
            <!--googleon: index-->
          
        </div>
        <script>SA.Pages.Article.handleDisclosures();</script>
        <div id="content_follow_up" class="underbar">
          <div id="follow_wrap">
              <div id="article_rta_bottom_container">
                <div id="related_promo_container_rel" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title">
      This article was sent to 
      <span id="promo_num_of_rta_rel">94</span>
      people who get email alerts on 
      <span class="replace_by_rel_slug">&nbsp;</span>.
    </div>
  </span>
  <div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel');">
    Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span>
  </div>
  <div class="m_pop point_left" id="promotion_box_rel" style="display:none;"></div>
</div>

<div id="related_promo_container_no_rel" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to
    <span id="dash_newsl_subscr_count_ph">
      371,443
    </span> people who get the Investing Ideas newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel', 10727)">
      Get the Investing Ideas newsletter &raquo;
    </span>
    <span id="promo_no_rel_loader" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel" style="display:none;"></div>
</div>
<div class="fl mb10" id="roadblock_comment_unit" style="display:none">
  <div class="comments_top_area">
    <div class="comments_top_area_half">
      <div class="comments_top_area_add"><strong>Comments</strong>
      	<span id="general_comment_counter">(<span id="comments_block"></span>)</span>
      </div>
    </div>
    <div style="color:#FF6F00">
      This article has&nbsp;
      <span id="comments_block2"></span>
      &nbsp;comments. To read them or add your own, <a href="javascript:void(0)" onclick="rb=new roadblock('article crb');rb.register_show=comments_reg_show;comments_reg_show()">click here</a>.
    </div>
  </div>
</div>

<div id="techpromo_container" style="display:none" class="fl mt30 mb30 w100">
  <div id="techpromo_button" onclick="SA.Pages.Article.sendTechPromoMail()"></div>
</div>

<div id="ipadpromo_container" style="display:none" class="fl mt30 mb30 w100">
  <div id='sms_promo_line1' class='sms_line1 ml90'>The #1 Portfolio App is Now on iPad!</div>
  <div id='sms_promo_line2' class='sms_line2 ml5 fwb mt10'>Get instant notifications & never miss a critical update on your stocks!</div>
  <a href="http://seekingalpha.com/download-ipad-app?source=article_ipad_app&kind=ipad" class="fl mt30"><div id="ipadpromo_button"></div></a>
  <a href="http://seekingalpha.com/download-ipad-app?source=article_ipad_app&kind=ipad" class="fl mt20"><div id="get_the_app"></div></a>
  <div id="ipadpromo_stars" class="fl mt15"></div>
</div>

<div id="store_container" style="display:none" class="fl mt30 mb30 w100">
  <div id='sms_promo_line1' class='sms_line1 ml25'>Which Seeking Alpha App is best for you?</div>
  <div class="mt15">
    <div class="ml25">
      <div class="fl"><input id="app_portfolio" type="checkbox"/></div>
      <div class="fl fwb ml10">Seeking Alpha Portfolio</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_tech" type="checkbox"/></div>
      <div class="fl fwb ml10">Tech Investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_etf" type="checkbox"/></div>
      <div class="fl fwb ml10">ETF investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="ml25 mt15">
      <div class="fl"><input id="app_energy" type="checkbox"/></div>
      <div class="fl fwb ml10">Energy Investor</div>
      <div class="cb"></div>
    </div><div class="cb"></div>
    <div class="light-gray mt20 ml25">Email me a link to open from my phone:</div>
    <div class="ml25 mt5">
      <input id="email_to_download" type="text" style="width: 300px" class="fl" emailautofill="on" title="Email address" empty="Email address"/>
      <div class="bs-btn fl btn-primary ml10 btn-mini fwb" style="width: 70px;" onclick="SA.Pages.Article.sendLinkDownload()">Continue</div>
      <div class="cb"></div>
      <div class="red fs11" id="email_td_error"></div>
    </div>
  </div>
</div>

<div id="web_video_container" style="display:none" class="fl mt30 mb30">
  <iframe width="480" height="315" src="//www.youtube.com/embed/LFNN6lhLtkk" frameborder="0" allowfullscreen></iframe>
  <div class="fl mt20" style="margin-left: 194px;"><a href="http://seekingalpha.com/download-app?source=vid_bottom_article">Get the app &raquo;</a></div>
</div>

<div id="ipad_video_container" style="display:none"  class="fl mt30 mb30">
  <iframe width="480" height="315" src="//www.youtube.com/embed/zEnMPGkjOnI" frameborder="0" allowfullscreen></iframe>
  <div class="fl mt20"  style="margin-left: 194px;"><a href="http://seekingalpha.com/download-app?source=vid_bottom_article">Get the app &raquo;</a></div>
</div>


              </div>
              <div id="article_rta_middle_container" style="display:none">
                <div id="related_promo_container_rel2" class="rta_bottom" style="display:none">
  <span class="title_wrap">
    <div class="rta_bottom_title" id="related_promo_title2">
      <span id="promo_num_of_rta_rel2">
         94
      </span>
         &nbsp;people received this article by email alert
         <span id="second_line_midelena"><br />Add your email to get alerts on <span class="replace_by_rel_slug">&nbsp;</span> too:</span>
    </div>
  </span>
  <div id="no_checkbox_midelena"><div class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('rel2')">Get email alerts on <span class="replace_by_rel_slug">&nbsp;</span><span class='rta_bottom_arrow'> &raquo;</span></div></div>
  <div class="m_pop point_left" id="promotion_box_rel2" style="display:none;"></div>
</div>
<div id="related_promo_container_no_rel2" class="rta_bottom newsletter" style="display:none">
  <div class="rta_bottom_title">
    This article was sent to <span id="dash_newsl_subscr_count_ph2">371,443</span> people who get the Investing Ideas newsletter.
    <span class="rta_bottom_lnk" onclick="SA.Pages.Article.relatedPromoAction('no_rel2', 10727)">Get the Investing Ideas newsletter &raquo;</span>
    <span id="promo_no_rel_loader2" style="display:none;"><img height="16" width="16" src="http://static3.cdn-seekingalpha.com/images/loader.gif" /></span>
  </div>
  <div class="m_pop" id="promotion_box_no_rel2" style="display:none;"></div>
</div>

              </div>
     		    <div id="article_tags" style="display:none">
              <div itemprop="articleSection" class="tagged_with">
                <span class="tagged_with_label">Tagged: </span><a href='/dashboard/investing_ideas' sasource='article_navigation'>Investing Ideas</a>, <a href='/analysis/investing-ideas/insider-ownership' sasource='article_navigation'>Insider Ownership</a>, <a href='/analysis/sectors/healthcare' sasource='article_navigation'>Healthcare</a>, <a href='/articles?filters=medical-instruments-supplies' sasource='article_navigation'>Medical Instruments &amp; Supplies</a>, <a href='/analysis/all/editors-picks' sasource='article_navigation'>Editors&#x27; Picks</a>, <a href='/articles?filters=small-cap-insight' sasource='article_navigation'>Small-Cap Insight</a>
              </div>
	          </div>
            <div class="share_this_page_article_bottom">
              <ul id="page_toolbar" class="page_toolbar">
  <li class="share_this_page_article_toolbar">
    <div class="share_this_page_snippet">
  <div id="first_line_info" style="width:490px">
    <div class="left"><h6><span id="share_slogan" class="fs16">Share this article with a colleague</span></h6></div>
  </div>
  <div class="widgets">
    <!-- Email -->

      <span class="email_this" onclick="email_story_to_friends('Article',1840392,'http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside')">
        <div class="email_button"></div>
        <div class="email_bubble">
          <span id="widget_email_count"></span>
          <span class="cor_right"></span>
        </div>
      </span>
    <!-- twitter -->
    <span class="twitter_small">
        <a href="https://twitter.com/share" class="twitter-share-button twitter_share" data-text="Erba Diagnostics: Future Consolidation Of Business Divisions Point To Significant Upside http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside?source=tweet $ERB" data-related="salphatrending" data-url=" " data-counturl="http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside?source=share" data-count="horizontal">Tweet</a>
    </span>
    <!-- Linked In -->
      <span id="linkedin_1" class="linkedin_small linkedin_share"><script type="IN/Share" data-counter="right" data-onsuccess="linkedin_callback"></script></span>
    <!-- facebook -->
    <span class="facebook_small facebook_share"><div class="fb-like" data-href="http://seekingalpha.com/article/1840392-erba-diagnostics-future-consolidation-of-business-divisions-point-to-significant-upside?source=facebook" data-send="false" data-layout="button_count" data-show-faces="false" data-font="tahoma"></div></span>
    <!-- Plusone  -->
      <span class="plusone_wrap"><span class="plusone plusone_share"><div class="g-plusone" data-size="medium" annotation="bubble" data-width="65" data-callback="plusone_callback"></div></span></span>
    <!-- print -->
      <span class="print_this" onclick="print_article('with_comments')"><Print><div class="print_button"></div></span>
  </div>
</div>

  <script>
    SeekingAlpha.Initializer.AddAfterLoad(function(){
      new Ajax.Updater({success: 'widget_email_count'}, '/form/ajax_get_email_count', {
        method: 'get',
        parameters: {
          item_name: 'Article',
          article_id: '1840392'
        }
      });
    });
  </script>
  </li>
</ul>            </div>
            <div class="bookmark_bottom_wrapper"><div id="bookmark_bottom" class="bookmark_container">
  <div id="bookmark_title_bottom" class="bookmark_title">BOOKMARK<span class="added">ED</span><span class="add"> / READ LATER</span></div></span>
  <div class="bookmark_popup" id="bookmark_popup_bottom">
    <h2>Bookmarked</h2>
    <p>Added to your bookmarks on the Seeking Alpha homepage</p>
    <div id="btn_bottom" class="btn">Remove Bookmark</div>
    <div class="arr"></div>
    <div class="right_cor"></div>
  </div>
</div>
<script>
 new SA.Pages.Article.bookmark("_bottom");
</script></div>
	          <div id="article_bottom_about" class="article_bottom_units"></div>
            <div id="more_by_auth" class="more_by_auth"></div>
            <div id="more_by_ticker" class="article_bottom_units"></div>
            <div id="temporary_place_holder" class="mt10"></div>
            <div class="cleaner"></div>
          </div>
            <div class="comments_with_more">
              <div id="comments_section">
              </div>
            </div>
          <div class="cleaner"></div>
          <span class="article_submit_an_article_big" onclick="submit_your_article();"></span>
        </div>
      </div>
      <div id="secondary_ads" class="no_big_gaps_secondary_ads" style="float:right;">
        <div id="author_avatar">
    <div class="follow_sidebar">
      <script>var author_info_popup_timeout;</script>
<div id="author_info"> 
  <div class="author_page_tools" id="author_image_header">
    <div class="author_info_wrap">
      <a href="/author/charles-fox" class='this_is_a_author_pic' sasource="about_lpic"><img class="this_is_a_author_pic_img" align="center" src="http://static.cdn-seekingalpha.com/images/users_profile/005/387/331/big_pic.png?1366049036" width="115" height="115" alt="Charles Fox picture" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();" /></a>
 <div id="goto_edit_picture" class="goto_edit_picture" style='display:none'><span onclick="return goto_update_picture();" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();"></span></div>
        <div id="article_author_info" style="display:none;" onmouseover="clearAuthorInfoPopupTimeout();" onmouseout="HideAuthorInfo();">
          <div>
            <div class="followup_contributor_info">
  <div class="followup_contributor_info_title">
    <span>About the author: </span>
    <a href="/author/charles-fox" sasource="about_name">Charles Fox</a>
  </div>

  <div class="followup_contributor_info_on_author">
    <div class="followup_contributor_info_pic_cont">
      <div class="pic_cont">
        <div class="pic_contributor">
          <div class="the_pic">
              <a href="/author/charles-fox" sasource="about_pic"><img align="center" width="54" height="54" src="http://static.cdn-seekingalpha.com/images/users_profile/005/387/331/big_pic.png?1366049036" alt="Charles Fox picture"/></a>
          </div>
        </div>
      </div>
    </div>
    <div class="followup_contributor_info_text">
      B.S. in Business Administration (Finance &amp; Managemet) Economics Minor Current MBA Student Emphasis in Corporate Finance, Investment Vehicles, and Technical Analysis Currently preparing for the Chartered Market Technician exams Ithaca, NY Westchester, NY I like to research/invest in heavily... <a href='/author/charles-fox' sasource='about_more'>More</a>
    </div>
    <div class="cleaner"></div>
	</div>
  <div class="followup_contributor_info_bottom_cnt">
    
    <div class="left_cnt">
      
    </div>
  </div>

  <div class="cleaner"></div>
</div>
<div class="followup_contributor_info_on_author_bottom"></div>

          </div>
        </div>
    </div>
    <a href="/author/charles-fox" itemprop="author" class="author_info_name" sasource="about_lname">Charles Fox</a>
    <div class="cleaner"></div>
    <div class="author_info_nav_border">
      <div class="author_info_nav">
        <ul class="the_author_info_nav">
          <li><a href='/author/charles-fox/articles'>Articles <span>(20)</span></a></li>
                        <li>
                   <a href='/author/charles-fox/stocktalk'>StockTalks <span>(3)</span></a>
                 </li>            <li>
                   <a href='/author/charles-fox/comments'>Comments <span>(101)</span></a>
                 </li>              <script>if (/stats viewer/.test(readCookie("user_perm"))) document.write("<li><a href='/account/authorboard/earnings?for_user_id=5387331'>Earnings</a></li>");</script>
          <li><a href='/author/charles-fox'>Profile</a></li>        </ul>
      </div>
    </div>
    <div class="cleaner"></div>
    <div class="user_followers_following">
      <div class="user_followers">
        <a href="/author/charles-fox/followers">
          <span id="followers" class="number followers_number_5387331 followers_number_charles-fox">169</span>
          <span class="text">Followers</span>
        </a>
      </div>
      <div class="user_followers">
        <a href="/author/charles-fox/following">
          <span id="followings" class="number">0</span>
          <span class="text">Following</span>
        </a>
      </div>
    </div>

    <div id="follow_this_user" class="follow_this_user"></div>
    <script>Follow.author_sidebar__follow_button_initiator('charles-fox')</script>
    <span class='author_info_send_message' onclick='Messaging.sendMessage("j3h22lpbf", "Article Author ID Card Upper")'>Send Message</span>
    <div class="cleaner"></div>
  </div>
  <div class="follow_popup_wrapper">
      <div class="green_pop_wrapper" id="stop_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('stop_follow').style.display='none'"></span><p><span id="stop_follow_message"></span> Charles Fox</p><span class="stop_following" onclick="Follow.ajax_stop_follow_this_author(this, 'charles-fox')">Stop Following</span></div></div><div class="green_pop_wrapper" id="no_longer_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('no_longer_follow').style.display='none'"></span><p><span id="no_longer_message"></span> Charles Fox</p></div></div>  </div>
</div>
  <script>SeekingAlpha.Initializer.onDOMLoad(function (){Follow.setFfToElements($('followers'),$('followings'),108452)})</script>

    </div>
    <div class="cleaner"></div>
    
    </div>
          <div class="stickyad_wrapper">
            <div class="item banner160x600" id="fixed_banner160x600">
            </div>
          </div>
      </div>
    </div>
      <script>var page_ad_src = 'http://ad.doubleclick.net/adj/sek.investing-ideas/insider-ownership;sz=300x251;x=x;tile=4;d=investing-ideas;pos=b;t=insider-ownership;aid=1840392;d=investing-ideas;d=sectors;t=insider-ownership;t=small-cap-insight;t=us;t=medical-instruments-supplies;t=editors-picks;t=healthcare;t=article;z=1;a=charles-fox;cnt=7;cnt=21;cnt=5;cnt=20;cnt=24;cnt=26;cnt=27;pr=erb;s=erb;'+dart_my_vocation_and_profiles()+'ord='+ord+'?';</script>
  <div id="ads_and_tools" class="article_sidebar_tools red_sidebar">
    <div class="item banner300x600">
      <script>add_js_to_ad_call('http://ad.doubleclick.net/adj/sek.investing-ideas/insider-ownership;sz=300x250,300x600;x=x;tile=2;d=investing-ideas;pos=t;t=insider-ownership;aid=1840392;d=investing-ideas;d=sectors;t=insider-ownership;t=small-cap-insight;t=us;t=medical-instruments-supplies;t=editors-picks;t=healthcare;t=article;z=1;a=charles-fox;cnt=7;cnt=21;cnt=5;cnt=20;cnt=24;cnt=26;cnt=27;pr=erb;s=erb;'+dart_my_vocation_and_profiles()+'ord='+ord+'?');</script>
    </div>
      <div id="alternative_title_container" class="mini_category data_currencies_table" style="display:none">
  <div class="sidebar_title_bk">
    <span class="sidebar_title_text" id="article_alternative_title"></span>			
  </div>
  <div id="symbol_alternative_tags" class="symbol_alternative_tags"></div>
  <div id="alternatives_pirsomet" class="alternatives_pirsomet" style="float:left;width:100%;"></div>
    <script type="text/javascript">
      ssga_always_display("Article_120x30", "http://9nl.it/i3eb/");
    </script>
  <div class="cleaner"></div>
</div>

<script type="text/javascript">
  symbol = "ERB";
  new Ajax.Request('/articles/get_ajax_alternatives_by_symbol?symbol='+symbol, {
    asynchronous:true,
    evalScripts:true,
    method:'get',
    onComplete: function(transport) {
      if (transport.status == 200 && transport.responseText != 'failed') {
        response = transport.responseText.split("@@");
        symbolZiignight = new Ziignight('', 'SAlternative',"","symbolZiignight","symbol_alternative_tags","ETF");
        symbolZiignight.WorkJSON = eval(response[1]);
        symbolZiignight.addETF = false;
        symbolZiignight.pageType = 'Article';
        symbolZiignight.selectedSymbol = symbol;
        symbolZiignight.SAlternativePrint(-1,true);
        symbolZiignight.InsertEtfAlternativeSymbol(response[0]);
        $('article_alternative_title').innerHTML = response[0].toUpperCase() + " vs. ETF alternatives";
        $("alternative_title_container").style.display = "";
      }
    }
  });
</script>


    <div id="register_login_snippet"></div>
    
    <div id="side_customize" class="side_customize"></div>
    <div id="portfolio_form_box"></div>

      <div id="article_sidebar" class="article_sidebar">
        <div id="sidebar_down"><img src="http://static.cdn-seekingalpha.com/images/loader_recommended_articles.gif" width="64" height="64" class="loader"/></div>
      </div>

    <div id="articles_on_my_portfolio"></div>
      <div class="cleaner"></div>
      <div class="stickyad_wrapper">
        <div class="item banner300x250" id="article_dart_sticky"></div>
      </div>
       
  </div>

  <script>
      SA.Utils.Ads.add({el:$('article_dart_sticky'), HadCreated:false, size:'300x250', delta:50, info:'http://ad.doubleclick.net/adj/sek.investing-ideas/insider-ownership;sz=300x251;x=x;tile=4;d=investing-ideas;pos=b;t=insider-ownership;aid=1840392;d=investing-ideas;d=sectors;t=insider-ownership;t=small-cap-insight;t=us;t=medical-instruments-supplies;t=editors-picks;t=healthcare;t=article;z=1;a=charles-fox;cnt=7;cnt=21;cnt=5;cnt=20;cnt=24;cnt=26;cnt=27;pr=erb;s=erb;'+dart_my_vocation_and_profiles()+'ord='+ord+'?'});
  </script>

<script src="http://static2.cdn-seekingalpha.com/javascripts/portfolio_form_popup_box_packaged.js?1384953999" type="text/javascript"></script>  
   </div>
  <input id="short_url" type="hidden" value="http://seekingalpha.com/a/13g20" />
</div>

<div id='footer_break'><div></div></div><div id="footer">
  <div id="footernav">
    <div class="footernav_left">
      <a href="http://seekingalpha.com" class="footernav_logo"></a>
      <div class="footernav_boards">
        <div><span class="footer_title">TOP AUTHORS:</span>&nbsp;<a class="top_authors" href="http://seekingalpha.com/leader-board/opinion-leaders">The Opinion Leaders</a></div>
        <div class='top_boards'>
          <span class="footer_title">TOP USERS:</span>
          <a href="http://seekingalpha.com/leader-board/top-stocktalkers">StockTalkers</a> <span class="fl_dash">|</span>
          <a href="http://seekingalpha.com/leader-board/top-instablogs">Instablogs</a>
        </div>    
      </div>
      <div class="cleaner"></div>
    </div>
    
     <div class="footernav_share_buttons">
       <div class="fl">
         <div class="fb-like" data-href="http://www.facebook.com/pages/Seeking-Alpha/224867310939090" data-layout="button_count" data-show-faces="false" data-font="verdana" data-width="450">Follow us</div>
       </div>
      <div class="twitter_wrap ml0 fl"><a href="https://twitter.com/SAlphaTrending" class="twitter-follow-button twitter_share" data-show-count="false">Follow us</a></div>
    </div>
    <div class="footernav_right">
      <div class="footernav_links">
        <a href="http://seekingalpha.com/page/sa-mobile-apps" sasource="footer">Mobile Apps</a>&nbsp;&nbsp;|&nbsp;
        <a class="small_rss" href="http://seekingalpha.com/page/feeds" sasource="footer">&nbsp;&nbsp;&nbsp;&nbsp;RSS Feeds</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/about_us" sasource="footer">About Us</a>&nbsp;&nbsp;|&nbsp;
        <a href="http://seekingalpha.com/page/contact" sasource="footer">Contact Us</a>
      </div>
      <div class="footernav_more_links">
        <a href="http://seekingalpha.com/page/terms-of-use" sasource="footer">Terms of Use</a> |
        <a href="http://seekingalpha.com/page/privacy" sasource="footer">Privacy</a> |
        <a href="http://www.xignite.com" rel="nofollow" target="_blank">Xignite quote data</a> |
        <span>&#169; 2013 Seeking Alpha</span>
      </div>
      <div class="cleaner"></div>
      
    </div>
   
  </div>
  <div class="cleaner"></div>
</div>  <script type="text/javascript">
    Event.observe(window, 'scroll', check_positions);

    NEW_AD_DELTA = typeof(CHANGE_AD_DELTA) != "undefined" ? CHANGE_AD_DELTA : 0;
    SA.Utils.Ads.add({el:$('fixed_banner160x600'), HadCreated:false, size:'160x600', delta:NEW_AD_DELTA, info:'http://ad.doubleclick.net/adj/sek.investing-ideas/insider-ownership;sz=160x600;x=x;tile=3;d=investing-ideas;t=insider-ownership;aid=1840392;d=investing-ideas;d=sectors;t=insider-ownership;t=small-cap-insight;t=us;t=medical-instruments-supplies;t=editors-picks;t=healthcare;t=article;z=1;a=charles-fox;cnt=7;cnt=21;cnt=5;cnt=20;cnt=24;cnt=26;cnt=27;pr=erb;s=erb;'+dart_my_vocation_and_profiles()+'ord='+ord+'?'});
  </script>
<script>
  document.observe('dom:loaded', function(){
    if ($('article_source')) {$('article_source').hide();}
    if (!is_pro) {$$('.arich_promobox').each(function(o){o.show()})}
    SA.Pages.Article.primary = "erb";
    SA.Pages.Article.init();
    if (typeof(propromotion) != "undefined") {propromotion();}

    if (SA.Pages.Article.alpha_rich_article() || SA.Pages.Article.insiders_report_article()){
      update_pro_tracker(0,1,0,0);
    }
      
    if (location.href.match(/source=[a-z0-9_]*email[a-z0-9_]*/)) {createCookie('camefromrta',true);}
    var pagination_version = ABTest.identity%10;

    if (SA.Pages.Article.is_roadblock()){
      rb = new roadblock('article');
      rb.register_show = SA.Pages.Article.roadshow;
      Mone.event(rb.type,rb.source,"Half Article");
      SA.Pages.Article.cut_new(pagination_version);
    } else {
      if (!SA.Data.User.loggedIn() && (location.search.match(/[?&]source=(yahoo|nasdaq)/)) && !document.cookie.match(/\b(user_id|user_email|camefromrta)=/)) {
        SA.Pages.Article.hide_features_for_roadblock();
      }
    }
    if (/no_ads/i.test(window.location.href)) {SA.Pages.Article.strip_for_iframe()}

      SA.Pages.Article.btb();

  });
    SeekingAlpha.Initializer.AddAfterLoad(function(){ 
      SA.Pages.Article.articlePromo({"allSlugs":["erb"],"primarySlug":"erb","dashboard_id":10727,"dashboard_title":"Investing Ideas"});
    });
</script>
      <script src="http://static2.cdn-seekingalpha.com/javascripts/jspell_packaged.js?1384954001" type="text/javascript"></script>
<link href="http://static2.cdn-seekingalpha.com/stylesheets/footer_packaged.css?1384954028" media="screen" rel="stylesheet" type="text/css" /><script type="text/javascript">
  if(typeof (authors) == "undefined" || typeof (symbols) == "undefined")
    load_remote_script("http://static.cdn-seekingalpha.com/javascripts/sa.js?1384953974");
  if(is_users_cookie_exists() && !cookieExists('tops') && typeof(tops) == "undefined")
    load_remote_script("http://static.cdn-seekingalpha.com/javascripts/tops.js?1384953751");
  Mone.renderedParams = {};
  SeekingAlpha.Initializer.AddAfterLoad(function(){SA.Performance.Utils.loadPrintStyle('http://static1.cdn-seekingalpha.com/stylesheets/print.css')});
</script>
<noscript>
  <img src="http://b.scorecardresearch.com/p?c1=2&c2=8500672&cv=2.0&cj=1" width="0" height="0" />
</noscript>
<script src="http://static.cdn-seekingalpha.com/javascripts/footer_packaged.js?1384953999" type="text/javascript"></script><div id="symbol_data_script_container"></div>
<script type="text/javascript">
SeekingAlpha.Initializer.onDOMLoad(function(){
  if(SA.Pages && SA.Pages.Account && SA.Pages.Account.Portfolios){
    var a = SA.Pages.Account.Portfolios.alertsTab;
    SA.Pages.Account.Portfolios.alertsTab = function(b){if ($('ziignight_submit')) a(b);}
if (getURLParam("pu")=="all_holdings") $("tab_"+Portfolio.current_tab).click();  
}
});
if (/\/account\/portfolio/.test(location.href)) {document.getElementsByTagName("html")[0].style.overflow = "auto"}
</script>
<style>
.portfolio_news #content_wrapper .left_content .market_currents ul#mc_news li  .bullet{* position: static;* padding:0 6px 6px 1px;}
</style>
<script>
var pubnub_test = '$|892165|17136652|12809951|52832|234601|946066|138138|119840|158117|3|6383|531163|9393711|4726401|1107427|2120371|2632411|';
try{
var auth = "|" + SA.Data.Cookies.get('user_id') + "|";
if (pubnub_test.indexOf(auth) > 0) {
var scriptElement_n = document.createElement("script");
scriptElement_n.defer = "defer";
scriptElement_n.src = 'http://static.cdn-seekingalpha.com/javascripts/utils/notify.js?144';
document.getElementsByTagName("head")[0].appendChild(scriptElement_n);
var scriptElement = document.createElement("script");
scriptElement.defer = "defer";
scriptElement.src = 'http://static.cdn-seekingalpha.com/javascripts/chat.js?148';
document.getElementsByTagName("head")[0].appendChild(scriptElement);
var fileref=document.createElement("link")
fileref.setAttribute("rel", "stylesheet")
fileref.setAttribute("type", "text/css")
fileref.setAttribute("href", "http://static.cdn-seekingalpha.com/stylesheets/chat.css?147")
document.getElementsByTagName("head")[0].appendChild(fileref)
}
} catch(e) {
}
</script>

<script type="text/javascript">if (typeof NREUMQ !== "undefined") { if (!NREUMQ.f) { NREUMQ.f=function() {
NREUMQ.push(["load",new Date().getTime()]);
var e=document.createElement("script");
e.type="text/javascript";
e.src=(("http:"===document.location.protocol)?"http:":"https:") + "//" +
  "js-agent.newrelic.com/nr-100.js";
document.body.appendChild(e);
if(NREUMQ.a)NREUMQ.a();
};
NREUMQ.a=window.onload;window.onload=NREUMQ.f;
};
NREUMQ.push(["nrfj","beacon-5.newrelic.com","c0370b1d43","334927,334964","cldeEUAJWgldEBsASkVRUwlXFRkWUA1D",0,61,new Date().getTime(),"","","","",""]);}</script>
    <div class="cleaner"></div>
  </body>
</html>
